| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO and President | President and CEO +1 more
1 company
Patel Mahesh V. serves as a Chief Executive Officer at LPCN. Across recent SEC filings that breaks down to 21 buys and 4 sells. Those positions are worth an estimated $326K at current prices.
Historically, Patel Mahesh V.'s trades have earned a below-average insider score of 43/100 across 8 rated trades. Over a 12-month horizon, 14.3% of those trades were profitable, with an average 12-month return of -36.4%.
The biggest single holding is LPCN (~$326K) as Chief Executive Officer. Net of sales, the recent Form 4 record there shows accumulation of 544,706 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2020 | LPCN Lipocine Inc. | Chief Executive Officer | Sale+OE | 43,500 | $1.57 | $68,134.05 | -3.9% | |
| Dec 31, 2019 | LPCN Lipocine Inc. | CEO and President | Buy | 40,000 | $0.38 | $15,340.00 | +4.3% | |
| Dec 10, 2019 | LPCN Lipocine Inc. | President and CEO | Buy | 25,000 | $0.40 | $9,975.00 | +2.8% | |
| Dec 4, 2019 | LPCN Lipocine Inc. | CEO and President | Sale+OE | 43,500 | $0.41 | $17,835.00 | -4.6% | |
| Nov 26, 2019 | LPCN Lipocine Inc. | President and CEO | Buy | 25,000 | $0.43 | $10,696.01 | +3.2% | |
| Nov 18, 2019 | LPCN Lipocine Inc. | CEO and President | Buy | 50,000 | $0.40 | $20,094.74 | +6.8% | |
| Dec 29, 2017 | LPCN Lipocine Inc. | CEO, President | Sale+OE | 6,000 | $3.48 | $20,866.80 | -0.8% | |
| Sep 30, 2015 | LPCN Lipocine Inc. | President and CEO | Buy | 4,000 | $11.84 | $47,354.73 | +0.5% |